• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过外显子组测序对一名患有慢性肠道假性梗阻的婴儿进行黏多糖贮积症I型的偶然诊断。

Incidental diagnosis of mucopolysaccharidosis type I in an infant with chronic intestinal pseudoobstruction by exome sequencing.

作者信息

Cospain Auriane, Dubourg Christèle, Gastineau Swellen, Pichard Samia, Gandemer Virginie, Bonneau Jacinthe, de Tayrac Marie, Moreau Caroline, Odent Sylvie, Pasquier Laurent, Damaj Lena, Lavillaureix Alinoë

机构信息

CHU Rennes, Service de Génétique Clinique, Centre de Référence Maladies Rares CLAD-Ouest, ERN ITHACA, Hôpital Sud, Rennes, France.

Univ Rennes, CNRS, IGDR, UMR 6290, Rennes F-35000, France.

出版信息

Mol Genet Metab Rep. 2020 Jul 7;24:100621. doi: 10.1016/j.ymgmr.2020.100621. eCollection 2020 Sep.

DOI:10.1016/j.ymgmr.2020.100621
PMID:32670797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7341448/
Abstract

Chronic intestinal pseudoobstruction (CIPO) is a severe form of intestinal dysmotility, and patients often undergo iterative abdominal surgeries and require parenteral nutrition. Several genes are known to be responsible for this pathology, including (autosomal dominant) and (autosomal recessive) We report the first case of unexpected trio medical exome sequencing diagnosis of mucopolysaccharidosis type I (MPS-I) in a patient with an early CIPO. There was no clinical suspicion of MPS-I at the time of the prescription. It allowed biochemical confirmation of MPS-I, expert clinical evaluation and early treatment. Enzyme replacement therapy (ERT) with laronidase was started at 9 months old, and hematopoietic stem cell transplantation was carried out at 10 months and a half. The patient also had a 1.7 mb heterozygous deletion in chromosomal region 16p13.11p12.3, comprising several genes, including paternally inherited. Her father has no symptoms of CIPO or other digestive symptoms. One previous association of CIPO and MPS-I was reported in 1986. Moreover, the number of incidental findings of inherited metabolic disorders with therapeutic impact will inevitably increase as pangenomic analyses become cheaper and easily available.

摘要

慢性肠道假性梗阻(CIPO)是一种严重的肠道运动障碍形式,患者常需反复接受腹部手术并需要肠外营养。已知有几个基因与这种病理状况有关,包括(常染色体显性)和(常染色体隐性)。我们报告了首例在早期CIPO患者中通过三联体医学外显子组测序意外诊断出I型黏多糖贮积症(MPS-I)的病例。在开具处方时,临床并未怀疑MPS-I。这使得能够对MPS-I进行生化确诊、专家临床评估及早期治疗。9个月大时开始使用拉罗尼酶进行酶替代疗法(ERT),10个半月时进行了造血干细胞移植。该患者在染色体区域16p13.11p12.3还存在一个1.7兆碱基的杂合缺失,其中包含几个基因,包括父系遗传的基因。她的父亲没有CIPO症状或其他消化症状。1986年曾报道过1例CIPO与MPS-I的关联病例。此外,随着泛基因组分析变得更便宜且易于获得,具有治疗意义的遗传性代谢疾病偶然发现的数量将不可避免地增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/7341448/c9a04c7b97d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/7341448/f038fbf642e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/7341448/c9a04c7b97d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/7341448/f038fbf642e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e71/7341448/c9a04c7b97d1/gr2.jpg

相似文献

1
Incidental diagnosis of mucopolysaccharidosis type I in an infant with chronic intestinal pseudoobstruction by exome sequencing.通过外显子组测序对一名患有慢性肠道假性梗阻的婴儿进行黏多糖贮积症I型的偶然诊断。
Mol Genet Metab Rep. 2020 Jul 7;24:100621. doi: 10.1016/j.ymgmr.2020.100621. eCollection 2020 Sep.
2
Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.早期酶替代疗法可使Ⅰ型黏多糖贮积症成功进行造血干细胞移植:两名日本兄妹的不同临床结局
Brain Dev. 2019 Jun;41(6):546-550. doi: 10.1016/j.braindev.2019.01.008. Epub 2019 Feb 10.
3
Mucopolysaccharidosis type I.I型黏多糖贮积症
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6.
4
Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿糖苷酶α)进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2013 Sep 26(9):CD009354. doi: 10.1002/14651858.CD009354.pub2.
5
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿糖苷酶α(商品名:Aldurazyme(®)))进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2013 Nov 21(11):CD009354. doi: 10.1002/14651858.CD009354.pub3.
6
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿糖苷酶α(Aldurazyme(®)))进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2016 Apr 1;4:CD009354. doi: 10.1002/14651858.CD009354.pub4.
7
Laronidase for the treatment of mucopolysaccharidosis type I.用于治疗I型黏多糖贮积症的拉罗尼酶
Expert Rev Endocrinol Metab. 2011 Nov;6(6):755-768. doi: 10.1586/eem.11.72.
8
Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.一名黏多糖贮积症I型患者接受拉罗尼酶酶替代疗法三年后的结果。
J Inherit Metab Dis. 2006 Dec;29(6):762. doi: 10.1007/s10545-006-0457-y. Epub 2006 Nov 6.
9
Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing.在慢性肠假性梗阻中鉴定出 MYH11 的显性致病变异:全外显子组测序的结果。
Clin Genet. 2019 Nov;96(5):473-477. doi: 10.1111/cge.13617. Epub 2019 Aug 13.
10
Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation.接受酶替代疗法加造血干细胞移植治疗的双胞胎黏多糖贮积症 I 型的长期演变
Heliyon. 2021 Aug 9;7(8):e07740. doi: 10.1016/j.heliyon.2021.e07740. eCollection 2021 Aug.

引用本文的文献

1
The Hidden Burden: Gastrointestinal Involvement in Lysosomal Storage Disorders.隐匿负担:溶酶体贮积症中的胃肠道受累
Metabolites. 2025 May 29;15(6):361. doi: 10.3390/metabo15060361.
2
Pseudoileus caused by primary visceral myopathy in a Han Chinese patient with a rare mutation: A case report.一名患有罕见突变的汉族患者原发性内脏肌病所致假性肠梗阻:病例报告
World J Clin Cases. 2022 Dec 6;10(34):12623-12630. doi: 10.12998/wjcc.v10.i34.12623.
3
Facial features of lysosomal storage disorders.溶酶体贮积症的面部特征。

本文引用的文献

1
Protein-elongating mutations in MYH11 are implicated in a dominantly inherited smooth muscle dysmotility syndrome with severe esophageal, gastric, and intestinal disease.MYH11 中的蛋白延伸突变与一种显性遗传的平滑肌运动障碍综合征有关,该综合征伴有严重的食管、胃和肠道疾病。
Hum Mutat. 2020 May;41(5):973-982. doi: 10.1002/humu.23986. Epub 2020 Feb 6.
2
Management of the Patient with Chronic Intestinal Pseudo-Obstruction and Intestinal Failure.慢性假性肠梗阻和肠衰竭患者的管理。
Gastroenterol Clin North Am. 2019 Dec;48(4):513-524. doi: 10.1016/j.gtc.2019.08.005. Epub 2019 Oct 8.
3
Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.
Expert Rev Endocrinol Metab. 2022 Nov;17(6):467-474. doi: 10.1080/17446651.2022.2144229. Epub 2022 Nov 16.
临床外显子测序中偶然发现报告标准 - 比利时遗传中心专业实践和观点的焦点小组研究。
BMC Med Genomics. 2019 Aug 20;12(1):123. doi: 10.1186/s12920-019-0561-0.
4
Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing.在慢性肠假性梗阻中鉴定出 MYH11 的显性致病变异:全外显子组测序的结果。
Clin Genet. 2019 Nov;96(5):473-477. doi: 10.1111/cge.13617. Epub 2019 Aug 13.
5
Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.黏多糖贮积症 I 型(MPS I)的基因型-表型关系:国际 MPS I 注册中心的见解。
Clin Genet. 2019 Oct;96(4):281-289. doi: 10.1111/cge.13583. Epub 2019 Jul 2.
6
Newly described recessive MYH11 disorder with clinical overlap of Multisystemic smooth muscle dysfunction and Megacystis microcolon hypoperistalsis syndromes.新描述的隐性MYH11障碍,与多系统平滑肌功能障碍和巨膀胱微结肠蠕动减弱综合征存在临床重叠。
Am J Med Genet A. 2018 Apr;176(4):1011-1014. doi: 10.1002/ajmg.a.38647.
7
Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.黏多糖贮积症 I 型(Hurler 综合征)系统治疗的长期疗效:一项国际多中心比较。
Genet Med. 2018 Nov;20(11):1423-1429. doi: 10.1038/gim.2018.29. Epub 2018 Mar 8.
8
Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis.静脉注射拉罗尼酶治疗黏多糖贮积症 I 型的疗效和安全性:一项系统评价和荟萃分析。
PLoS One. 2017 Aug 31;12(8):e0184065. doi: 10.1371/journal.pone.0184065. eCollection 2017.
9
Diagnosis of Chronic Intestinal Pseudo-obstruction and Megacystis by Sequencing the ACTG2 Gene.通过对ACTG2基因进行测序诊断慢性肠假性梗阻和巨膀胱症。
J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):384-387. doi: 10.1097/MPG.0000000000001608.
10
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management.Ⅰ型黏多糖贮积症新生儿筛查:诊断与管理的最佳实践
J Pediatr. 2017 Mar;182:363-370. doi: 10.1016/j.jpeds.2016.11.036. Epub 2016 Dec 7.